106 related articles for article (PubMed ID: 33161089)
41. Identification and characterization of HPV-independent cervical cancers.
Banister CE; Liu C; Pirisi L; Creek KE; Buckhaults PJ
Oncotarget; 2017 Feb; 8(8):13375-13386. PubMed ID: 28077784
[TBL] [Abstract][Full Text] [Related]
42. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
43. Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.
El-Zein M; Cheishvili D; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Szyf M; Franco EL;
Int J Cancer; 2020 Sep; 147(5):1264-1274. PubMed ID: 31983058
[TBL] [Abstract][Full Text] [Related]
44. Differential methylation and expression patterns of microRNAs in relation to breast cancer subtypes among American women of African and European ancestry.
Gong Z; Chen J; Wang J; Liu S; Ambrosone CB; Higgins MJ
PLoS One; 2021; 16(3):e0249229. PubMed ID: 33784351
[TBL] [Abstract][Full Text] [Related]
45. Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.
Chang CC; Huang RL; Liao YP; Su PH; Hsu YW; Wang HC; Tien CY; Yu MH; Lin YW; Lai HC
BMC Cancer; 2015 May; 15():418. PubMed ID: 25985991
[TBL] [Abstract][Full Text] [Related]
46. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells.
Zhang Y; Chen FQ; Sun YH; Zhou SY; Li TY; Chen R
J Exp Clin Cancer Res; 2011 Oct; 30(1):98. PubMed ID: 21999220
[TBL] [Abstract][Full Text] [Related]
47. Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy.
Lim EH; Ng SL; Li JL; Chang AR; Ng J; Ilancheran A; Low J; Quek SC; Tay EH
Gynecol Oncol; 2010 Nov; 119(2):225-31. PubMed ID: 20708786
[TBL] [Abstract][Full Text] [Related]
48. Identification of novel DNA methylation markers in cervical cancer.
Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
[TBL] [Abstract][Full Text] [Related]
49. Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.
Verlaat W; Snijders PJF; Novianti PW; Wilting SM; De Strooper LMA; Trooskens G; Vandersmissen J; Van Criekinge W; Wisman GBA; Meijer CJLM; Heideman DAM; Steenbergen RDM
Clin Cancer Res; 2017 Jul; 23(14):3813-3822. PubMed ID: 28119363
[No Abstract] [Full Text] [Related]
50. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.
Flatley JE; McNeir K; Balasubramani L; Tidy J; Stuart EL; Young TA; Powers HJ
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2782-9. PubMed ID: 19755648
[TBL] [Abstract][Full Text] [Related]
51. Accounting for population stratification in DNA methylation studies.
Barfield RT; Almli LM; Kilaru V; Smith AK; Mercer KB; Duncan R; Klengel T; Mehta D; Binder EB; Epstein MP; Ressler KJ; Conneely KN
Genet Epidemiol; 2014 Apr; 38(3):231-41. PubMed ID: 24478250
[TBL] [Abstract][Full Text] [Related]
52. Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p.
Rader JS; Gerhard DS; O'Sullivan MJ; Li Y; Li L; Liapis H; Huettner PC
Genes Chromosomes Cancer; 1998 May; 22(1):57-65. PubMed ID: 9591635
[TBL] [Abstract][Full Text] [Related]
53. Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes.
Teixeira da Costa Lodi C; Michelin MA; Miranda Lima MI; Murta EFC; Braga LDC; Montes L; Melo VH
Arch Gynecol Obstet; 2018 Nov; 298(5):971-979. PubMed ID: 30218185
[TBL] [Abstract][Full Text] [Related]
54. Characterizing methylation regulated miRNA in carcinoma of the human uterine cervix.
Varghese VK; Shukla V; Jishnu PV; Kabekkodu SP; Pandey D; Sharan K; Satyamoorthy K
Life Sci; 2019 Sep; 232():116668. PubMed ID: 31326568
[TBL] [Abstract][Full Text] [Related]
55. Correlation between Methylation of Human Papillomavirus-16 L1 Gene and Cervical Carcinoma in Uyghur Women.
Niyazi M; Sui S; Zhu K; Wang L; Jiao Z; Lu P
Gynecol Obstet Invest; 2017; 82(1):22-29. PubMed ID: 26954462
[TBL] [Abstract][Full Text] [Related]
56. Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer.
Zhang J; Yao T; Lin Z; Gao Y
Sci Rep; 2017 Jul; 7(1):6271. PubMed ID: 28740189
[TBL] [Abstract][Full Text] [Related]
57. Detection of methylation of the promoter region of the MAL and CADM1 genes by pyrosequencing in cervical carcinoma.
Mersakova S; Visnovsky J; Holubekova V; Nachajova M; Kudela E; Danko J; Lasabova Z
Neuro Endocrinol Lett; 2014; 35(7):619-23. PubMed ID: 25617886
[TBL] [Abstract][Full Text] [Related]
58. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P
PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087
[TBL] [Abstract][Full Text] [Related]
59. DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions.
Gomih A; Smith JS; North KE; Hudgens MG; Brewster WR; Huang Z; Skaar D; Valea F; Bentley RC; Vidal AC; Maguire RL; Jirtle RL; Murphy SK; Hoyo C
Int J Cancer; 2018 Aug; 143(3):552-560. PubMed ID: 29490428
[TBL] [Abstract][Full Text] [Related]
60. Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer.
Farkas SA; Milutin-Gašperov N; Grce M; Nilsson TK
Epigenetics; 2013 Nov; 8(11):1213-25. PubMed ID: 24030264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
